{
    "2018-05-16": [
        [
            {
                "time": "",
                "original_text": "[强于大市评级]部分医药个股纳入MSCI点评(医药生物行业)：医药部分个股纳入MSCI 看好长期价值",
                "features": {
                    "keywords": [
                        "MSCI",
                        "医药",
                        "生物",
                        "个股",
                        "长期价值"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]凯莱英(002821)重大事项点评：加入MSCI指数体系 获国际资本市场认可",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "MSCI",
                        "指数体系",
                        "国际资本市场",
                        "认可"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}